All the abovementioned results strongly support our claim that ATAD2 is positively associated with cancer stemness, regardless of the tumor type and this association might be mediated at least partially by the interaction with the c‐Myc transcription factor—an essential factor facilitating the acquisition and maintenance of stem cell properties. The gene discussed is ATAD2; the disease is cancer.